ABG
COGT icon

Ally Bridge Group’s Cogent Biosciences COGT Stock Holding History

Ally Bridge Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-204,014
Closed -$3.04M – 33
2022
Q3 		$3.04M Sell
204,014
-653,338
-76% -$8.96M 2.01% 22
2022
Q2 		$7.73M Sell
857,352
-452,078
-35% -$3.09M 7.05% 3
2022
Q1 		$9.81M Sell
1,309,430
-192,161
-13% -$1.34M 7.27% 5
2021
Q4 		$12.9M Sell
1,501,591
-121,000
-7% -$1.05M 4.5% 6
2021
Q3 		$13.6M Hold
1,622,591
– – 4.01% 12
2021
Q2 		$13.2M Hold
1,622,591
– – 3.27% 16
2021
Q1 		$14.2M Hold
1,622,591
– – 2.73% 11
2020
Q4 		$18.2M Buy
+1,622,591
New +$17.8M 3.12% 9

Other funds holding COGT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Ally Bridge Group's COGT Position: Q4 2022 in Review

Ally Bridge Group sold out of Cogent Biosciences (COGT) in Q4 2022, closing a stake of 204,014 shares — an estimated $3.04M sold.

Ally Bridge Group first reported a position in COGT in Q4 2020 and held it in 8 quarters. The position peaked at $18.2M in Q4 2020. 135 funds tracked by Wall St. Rank hold COGT as of Q4 2022.

  • Ally Bridge Group reported no remaining Cogent Biosciences position as of Q4 2022 after selling out during the quarter.
  • Ally Bridge Group sold 204,014 Cogent Biosciences shares in Q4 2022, an estimated $3.04M.
  • Ally Bridge Group first reported a position in Cogent Biosciences in Q4 2020 and held it in 8 quarters.
  • Ally Bridge Group's Cogent Biosciences position peaked at $18.2M in Q4 2020.
  • 135 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2022.

Based on Ally Bridge Group's 13F filing for Q4 2022, filed 14 Feb 2023.